Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued to investors on Wednesday morning. The brokerage issued a hold rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 target price on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Stock Performance

Shares of Milestone Scientific stock opened at $1.26 on Wednesday. The company’s fifty day moving average is $1.01 and its two-hundred day moving average is $0.94. Milestone Scientific has a 1 year low of $0.54 and a 1 year high of $1.39. The company has a market capitalization of $98.14 million, a P/E ratio of -18.00 and a beta of 1.10.

Hedge Funds Weigh In On Milestone Scientific

Large investors have recently made changes to their positions in the stock. Geode Capital Management LLC grew its position in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares during the period. World Investment Advisors LLC purchased a new stake in shares of Milestone Scientific during the 3rd quarter worth approximately $91,000. Y Intercept Hong Kong Ltd acquired a new stake in shares of Milestone Scientific in the 3rd quarter worth approximately $48,000. Finally, Carnegie Investment Counsel increased its stake in Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares in the last quarter. Hedge funds and other institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.